Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images

Lung Cancer

Volumn 45, Issue 1, 2004, Pages 19-27

  Nomori, Hiroaki ^a   Watanabe, Kenichi ^a   Ohtsuka, Takashi ^a   Naruke, Tsuguo ^a   Suemasu, Keiichi ^a   Uno, Kimiichi ^b  

^a SAISEIKAI CENTRAL HOSPITAL   (Japan)

^b Nishidai Clinic   (Japan)

Author keywords

Computed tomography; FDG PET; Ground glass opacity; Lung cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER DIAGNOSIS; CANCER SIZE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; HISTOGRAM; HISTOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG NODULE; LUNG TUMOR; MAJOR CLINICAL STUDY; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR CLASSIFICATION; TUMOR VOLUME;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 2942547509     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.01.009     Document Type: Article

References (26)

1. Kaneko M., Eguchi K., Ohmatsu H., et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology. 201:1996;798-802
2. Yankelevitz D.F., Gupta R., Zhao B., et al. Small pulmonary nodules: evaluation with repeat CT-preliminary experience. Radiology. 212:1999;561-566
3. Henschke C.I., Yankelevitz D.F. CT screening for lung cancer. Radiol. Clin. North Am. 38:2000;487-495
4. Nomori H., Horio H., Fuyuno G., Kobayashi R., Morinaga S., Suemasu K. Lung adenocarcinomas diagnosed by open or thoracoscopic vs. bronchoscopic biopsy. Chest. 114:1998;40-44
5. 18F ] fluorodeoxyglucose Ann. Thorac. Surg. 58:1994;698-703
6. Patz E.F., Lowe V.J., Hoffman J.M., et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology. 188:1993;487-490
7. Gupta N.C., Maloof J., Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J. Nucl. Med. 37:1996;943-948
8. Gupta N.C., Gill H., Graeber G., et al. Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions. Chest. 114:1998;1105-1111
9. Gambhir S.S., Shepherd J.E., Shah B.D., et al. Analytical decision model for the cost-effectiveness management of solitary pulmonary nodules. J. Clin. Oncol. 16:1998;2113-2125
10. Dewan N.A., Gupta N.C., Redepenning L.S., et al. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest. 104:1993;997-1002
11. Higashi K., Ueda Y., Seki H., et al. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar carcinoma. J. Nucl. Med. 39:1998;1016-1020
12. Imdahl A., Jenkner S., Brink I., et al. Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions. Eur. J. Cardio-Thoracic Surg. 20:2001;324-329
13. Coleman R.E. PET in lung cancer. J. Nucl. Med. 40:1999;814-820
14. McLoud T.C. Imaging techniques for diagnosis and staging of lung cancer. Clinics Chest Med. 23:2002;123-136
15. Lowe V.J., Fletcher J.W., Gobar L., et al. Prospective investigation of positron emission tomography in lung nodules. J. Clin. Oncol. 16:1998;1075-1084
16. Collins J., Stern E.J. Ground-glass opacity at CT: the ABCs. Am. J. Roentgenol. 169:1997;355-367
17. Nomori H., Ohtsuka T., Naruke T., Suemasu K. Differentiating between atypical adenomatous hyperplasia and bronchiolo-alveolar carcinoma using the computed tomography number histogram. Ann. Thorac. Surg. 76:2003;867-871
18. Nomori H., Ohtsuka T., Naruke T., et al. Histogram analysis of computed tomography numbers of clinical T1N0M0 lung adenocarcinoma, with special reference to lymph node metastasis and tumor invasiveness. J. Thorac. Cardiovasc. Surg. 126:2003;1584-1589
19. Moses L.E., Shapiro D., Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat. Med. 12:1993;1293-1316
20. Gould M.K., Maclean C.C., Kuschner W.G., Rydzak C.E., Owens D.K. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA. 285:2001;914-924
21. Marom E.M., Sarvis S., Herndon J.E., et al. T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET. Radiology. 223:2002;453-459
22. Lowe V.J., Hoffman J.M., DeLong D.M., et al. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J. Nucl. Med. 35:1994;1771-1776
23. Wahl R.L., Cody R.L., Hutchins G.D., et al. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology. 179:1991;765-770
24. Uno K., Yoshikawa K., Imazeki K., Okada J., Minoshima S., Arimizu N. FDG-PET evaluation of breast carcer: a diagnostic role for primary or metastatic and recurrent lesions. Radiology. 185:1992;108
25. 18F -FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer J. Nucl. Med. 43:2002;39-45
26. Keyes J.W. Jr. SUV: standard uptake or silly useless value? J. Nucl. Med. 36:1995;1836-1839